Navigation and service

You are here:Other risk informations

Carbomedac®: BfArM's recommendation to filter the medicinal product is cancelled

Date 2016.05.19
Active substance Carboplatin

The company Medac Gesellschaft für klinische Spezialpräparate mbH has submitted documents to the BfArM proving that filtering the medicinal product Carbomedac® prior to use as recommended until now by the BfArM is no longer necessary.